Skip to main content
Literatur
1.
Zurück zum Zitat Tempero MA (2019) NCCN Guidelines Updates: Pancreatic Cancer. 17: 603 Tempero MA (2019) NCCN Guidelines Updates: Pancreatic Cancer. 17: 603
3.
Zurück zum Zitat O’Hara MH, O’Reilly EM, Rosemarie M, et al (2019) Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients. Cancer Research 79: CT004-CT004 O’Hara MH, O’Reilly EM, Rosemarie M, et al (2019) Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients. Cancer Research 79: CT004-CT004
5.
Zurück zum Zitat Murphy JE, Wo JY, Ryan DP, et al (2019) Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. JAMA Oncol 5: 1020-1027CrossRef Murphy JE, Wo JY, Ryan DP, et al (2019) Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. JAMA Oncol 5: 1020-1027CrossRef
Metadaten
Titel
Report from the pancreatic ductal adenocarcinoma disease focused panel
Publikationsdatum
17.10.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02261-3

Weitere Artikel der Ausgabe 12/2019

Abdominal Radiology 12/2019 Zur Ausgabe

Special Section: Urothelial Disease

Imaging of the female urethra

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.